<DOC>
	<DOCNO>NCT00635362</DOCNO>
	<brief_summary>The study randomize control trial compare outcome immediate postplacental insertion levonorgestrel-releasing intrauterine system ( LNG-IUS ) vs. interval insertion LNG-IUS perform 4-8 week delivery patient undergo schedule cesarean delivery . Our primary hypothesis proportion woman use LNG-IUS contraception 12 month delivery high group randomize immediate post-placental insertion .</brief_summary>
	<brief_title>Postplacental Insertion Levonorgestrel-releasing Intrauterine System ( LNG-IUS ) After Cesarean vs. Interval Insertion</brief_title>
	<detailed_description />
	<mesh_term>Levonorgestrel</mesh_term>
	<criteria>Pregnant time enrollment Planning undergo schedule cesarean delivery Desires use LNGIUS contraception Willing able sign inform consent English Willing comply study protocol Age great equal 18 year English speaking Allergy either polyethylene levonorgestrel , contraindication use LNGIUS Positive test Gonorrhea , Chlamydia , trichomoniasis pregnancy without treatment subsequent test cure confirm negative result Presence leiomyomata significantly distort uterine cavity thus allow placement LNGIUS Uterine anomaly would allow placement LNGIUS Current cervical cancer carcinoma insitu Desire repeat pregnancy le 12 month History postabortal postpartum sepsis</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Contraception</keyword>
	<keyword>Contraceptive Devices</keyword>
	<keyword>Intrauterine Devices</keyword>
	<keyword>Unplanned Pregnancy</keyword>
	<keyword>Postpartum Period</keyword>
</DOC>